# Bank of New York Mellon Corp: overview

BNY · NYSE · CIK 1390777 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bny.md) · [Financials](/companies/bny/financials.md) · [Filings](/companies/bny/filings.md) · [Insiders](/companies/bny/insiders.md)

Latest reported revenue: [$2.89bn](/filings/0001390777-18-000113.md) for Q2 FY2018, three months to 2018-06-30, from the 10-Q filed Aug 3, 2018 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001390777-18-000113).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [1.54](/filings/0001390777-25-000084.md) | [1.58](/filings/0001390777-26-000060.md) | [1.93](/filings/0001390777-26-000086.md) | [1.88](/filings/0001390777-26-000120.md) | not reported | [2.24](/filings/0001390777-26-000060.md) | [2.45](/filings/0001390777-26-000086.md) | [2.34](/filings/0001390777-26-000120.md) |
| Free cash flow | $m | [1,137 d](/filings/0001390777-26-000033.md) | [92.0](/filings/0001390777-26-000060.md) | [1,838 d](/filings/0001390777-26-000086.md) | [(1,502) d](/filings/0001390777-26-000120.md) | [4,749 d](/filings/0001390777-26-000033.md) | [(3,630)](/filings/0001390777-26-000060.md) | [1,975 d](/filings/0001390777-26-000086.md) | [4,050 d](/filings/0001390777-26-000120.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [15.9](/filings/0001390777-24-000051.md) | [16.5](/filings/0001390777-25-000046.md) | [17.7](/filings/0001390777-26-000033.md) | [18.6](/filings/0001390777-26-000033.md) | [20.1](/filings/0001390777-26-000033.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [23.6%](/filings/0001390777-24-000051.md) | [15.5%](/filings/0001390777-25-000046.md) | [18.7%](/filings/0001390777-26-000033.md) | [24.3%](/filings/0001390777-26-000033.md) | [27.6%](/filings/0001390777-26-000033.md) |
| Diluted EPS | $ per share | [4.14](/filings/0001390777-24-000051.md) | [2.88](/filings/0001390777-25-000046.md) | [3.89](/filings/0001390777-26-000033.md) | [5.80](/filings/0001390777-26-000033.md) | [7.40](/filings/0001390777-26-000033.md) |
| Free cash flow | $bn | [1.6](/filings/0001390777-24-000051.md) | [13.7](/filings/0001390777-25-000046.md) | [4.7](/filings/0001390777-26-000033.md) | [(0.8)](/filings/0001390777-26-000033.md) | [5.2](/filings/0001390777-26-000033.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bny/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-27 | [Vince Robin A.](/insiders/1825740.md) | Chairman & CEO, Director, Officer | Sale (S) | 9,380 | $147.8206 | $1.4m | [Form 4](/filings/0001193125-26-436233.md) |
| 2026-10-27 | [Minaya Jose](/insiders/1950068.md) | Senior Executive VP, Officer | Sale (S) | 445 | $148.2239 | $66.0k | [Form 4](/filings/0001193125-26-437816.md) |
| 2026-10-27 | [Minaya Jose](/insiders/1950068.md) | Senior Executive VP, Officer | Sale (S) | 3,075 | $147.7459 | $454.3k | [Form 4](/filings/0001193125-26-437816.md) |
| 2026-10-26 | [Vince Robin A.](/insiders/1825740.md) | Chairman & CEO, Director, Officer | Sale (S) | 40,620 | $147.8113 | $6.0m | [Form 4](/filings/0001193125-26-436233.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $8.32bn | 57,541,743 |  | Reduced −4,064,767 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $6.48bn | 44,809,159 |  | Added +142,406 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $4.60bn | 31,781,330 |  | Added +20,729 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $3.75bn | 25,913,108 |  | Reduced −1,413,064 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $2.55bn | 17,652,500 |  | Reduced −1,246,655 |
| [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $2.50bn | 17,283,991 |  | Added +620,022 |
| [Dodge & Cox](/funds/200217.md) | 2026-06-30 | $2.40bn | 16,608,370 |  | Reduced −6,793,424 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $2.27bn | 15,777,525 |  | Reduced −2,919,041 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $2.13bn | 14,790,798 |  | Reduced −102,134 |
| [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $2.10bn | 14,552,355 |  | Added +27,298 |

## Recent filings

[All 3,705 filings](/companies/bny/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 07:02 ET | [10-Q](/filings/0001390777-26-000120.md) | Quarterly report, period 2026-09-30 | 0001390777-26-000120 |
| 2026-10-28 | 17:00 ET | [8-K](/filings/0001193125-26-436302.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-436302 |
| 2026-10-16 | 16:19 ET | [8-K/A](/filings/0001390777-26-000106.md) | 5.02 Departure or appointment of officers or directors | 0001390777-26-000106 |
| 2026-10-15 | 06:30 ET | [8-K](/filings/0001390777-26-000104.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001390777-26-000104 |
| 2026-09-22 | 16:21 ET | [8-K](/filings/0001390777-26-000097.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001390777-26-000097 |
| 2026-08-20 | 09:13 ET | [8-K](/filings/0001193125-26-358252.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-358252 |
| 2026-08-13 | 16:31 ET | [8-K](/filings/0001193125-26-349341.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-349341 |
| 2026-08-12 | 16:52 ET | [8-K](/filings/0001193125-26-347061.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-347061 |
| 2026-07-31 | 16:31 ET | [10-Q](/filings/0001390777-26-000086.md) | Quarterly report, period 2026-06-30 | 0001390777-26-000086 |
| 2026-07-23 | 16:42 ET | [8-K](/filings/0001193125-26-314242.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-314242 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001390777-26-000033.md), filed Feb 25, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1390777
- Tickers: BNY, BNY-PK
- Exchange: NYSE
- SIC code: 6022 State Commercial Banks
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 31, 2026, 02:46 ET. No prices; not investment advice.